"This book summarizes the state of the art in process analytical technologies applied to various aspects of biopharmaceutical process development and manufacturing. The text summarizes regulatory perspectives, FDA/EMEA guidelines, and new expectations. In addition, it explores n…
"Companies are increasingly asking which of their value chain activities are best performed within their own company and which may be outsourced. In addition, they are also considering which pieces of their value chain may be better performed abroad. These interrelated decisions…
" The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development ( R & D ) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and in…
"A persuasive look at why some U.S. cities have prospered in recent decades while others have declined."--Bloomberg Businessweek We're used to thinking of the United States in opposing terms: red versus blue, haves versus have-nots. But today there are three Americas. At one ext…
Business model innovation is the new strategic imperative for all leaders. Blockbuster's executives saw Netflix coming. Yet they stuck with their bricks and mortar business model, losing billions in shareholder value. They were "netflixed." Business models don't last as long as …
